The ins and outs of osteopontin
Open Access
- 22 January 2015
- journal article
- Published by Taylor & Francis in OncoImmunology
- Vol. 4 (3) , e978711
Abstract
The continuous remodeling of progressing tumors demands non-physiologic production of extracellular matrix (ECM) proteins. Among them, osteopontin (OPN) has been largely involved in tumor progression and metastasis. We have recently discovered a new mechanism for OPN in the metastatic spread of mammary carcinoma providing local immunosuppression at the seeding site.Keywords
This publication has 9 references indexed in Scilit:
- Osteopontin Shapes Immunosuppression in the Metastatic NicheCancer Research, 2014
- Coordinated regulation of myeloid cells by tumoursNature Reviews Immunology, 2012
- Matricellular proteins: from homeostasis to inflammation, cancer, and metastasisCancer and Metastasis Reviews, 2010
- Alternative translation of osteopontin generates intracellular and secreted isoforms that mediate distinct biological activities in dendritic cellsProceedings of the National Academy of Sciences, 2008
- The Terminology Issue for Myeloid-Derived Suppressor CellsCancer Research, 2007
- Serial Plasma Osteopontin Levels Have Prognostic Value in Metastatic Breast CancerClinical Cancer Research, 2006
- Osteopontin expression is essential for interferon-α production by plasmacytoid dendritic cellsNature Immunology, 2006
- Gr-1+CD115+ Immature Myeloid Suppressor Cells Mediate the Development of Tumor-Induced T Regulatory Cells and T-Cell Anergy in Tumor-Bearing HostCancer Research, 2006
- Eta-1 (Osteopontin): An Early Component of Type-1 (Cell-Mediated) ImmunityScience, 2000